Caveolin-1 regulation of disrupted-in-schizophrenia-1 as a potential therapeutic target for schizophrenia.
Kassan A, Egawa J, Zhang Z, Almenar-Queralt A, Nguyen QM, Lajevardi Y, Kim K, Posadas E, Jeste DV, Roth DM, Patel PM, Patel HH, Head BP.
Kassan A, et al. Among authors: patel pm, patel hh.
J Neurophysiol. 2017 Jan 1;117(1):436-444. doi: 10.1152/jn.00481.2016. Epub 2016 Nov 2.
J Neurophysiol. 2017.
PMID: 27832597
Free PMC article.